BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Drug Discovery

Leading Scientists Unite at OrganoAsia 2a025 to Advance Organoid Research and Industrial Applications

Leading Scientists from China, Japan and South Korea Convene to Drive Organoid Research and Commercialization ACROBiosystems, tog...

October 13, 2025 | Report

C-Ray Therapeutics Commends Biokin on NMPA Approval for Groundbreaking [177Lu]-BL-ARC001 Radiopharmaceutical

C-Ray Therapeutics (Chengdu) Co.,Ltd proudly congratulates its strategic partner, Biokin Pharmaceutical, on receiving implied approval from the N...

October 13, 2025 | News

Chance Pharmaceuticals and Huadong Medicine Partner for Exclusive Commercialisation of CXG87 in China

Chance Pharmaceuticals ("Chance" or "Chance Pharma"), a clinical-stage biotechnology company dedicated to the research and development of innovative inhala...

October 10, 2025 | News

Alithea Genomics Launches MERCURIUS™ Spheroid DRUG-seq to Transform 3D Transcriptomic Drug Screening

Alithea Genomics, a leader in next-generation transcriptomic solutions, announced the commercial launch of MERCURIUS™ Spheroid DRUG-seq, a...

October 10, 2025 | News

Anasens Partners with MAVAND Solutions to Expand DrugAsens™ Rapid Oral-Fluid Drug Testing Across Europe and Australia

Anasens Inc., a developer of rapid, connected point-of-care detection tools, announced it has signed a distribution agreement with MAVAND Soluti...

October 08, 2025 | News

MOLCURE and Boehringer Ingelheim Forge AI-Powered Alliance to Accelerate Antibody Drug Discovery

MOLCURE Inc. announced that it has entered into a multi-year strategic research agreement with Boehringer Ingelheim for the discovery of innovative an...

October 08, 2025 | News

Japan Grants National Reimbursement for MedHub-AI AutocathFFR Marking a Breakthrough in AI-Driven Coronary Physiology

MedHub-AI announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) has approved national reimbursement for the company's Autoca...

October 06, 2025 | News

Nanyang Biologics to Go Public Through Business Combination with RF Acquisition Corp II Valued at 1.5 Billion USD

Nanyang Biologics Pte. Ltd., together with its subsidiaries (collectively, the "Company", "we" or "NYB"), offers a comprehensive drug discovery platform ...

October 03, 2025 | News

Celltrion Launches AVTOZMA IV FDA Approved Tocilizumab Biosimilar in United States

The AVTOZMA® (tocilizumab-anoh) intravenous (IV) formulation was approved in January 2025 by the FDA to treat the same conditions as t...

October 03, 2025 | News

JCR Pharmaceuticals Grants Menagen Exclusive Rights to Commercialise Fabry Therapy Across MENAT Region

JCR Pharmaceuticals Co., Ltd. a global specialty biopharmaceutical company dedicated to developing therapies for rare and genetic diseases, announced ...

October 03, 2025 | News

Thermo Fisher’s PPD™ Clinical Research Joins AstraZeneca BioVentureHub for R&D Partnership in Sweden

The PPD™ clinical research business of Thermo Fisher Scientific, the world leader in serving science, announced a new research and development ...

October 02, 2025 | News

Japan Grants Orphan Drug Designation to JR-446 for Sanfilippo Syndrome Type B

MEDIPAL HOLDINGS CORPORATION and JCR Pharmaceuticals Co., Ltd. announced that the Ministry of Health, Labour and Welfare of Japa...

October 01, 2025 | News

AbbVie Submits FDA Application for Tavapadon After Positive Phase 3 TEMPO Results in Parkinson’s Disease

Submission supported by data from the Phase 3 TEMPO program that demonstrated symptomatic improvement across the Parkinson's disease spectrum Positive r...

September 29, 2025 | News

Merck and Siemens Forge Digital Alliance to Transform Drug Discovery and Manufacturing

Memorandum of Understanding signed to deliver end-to-end digital workflows from drug discovery to manufacturing Combines technology from the Siemens...

September 24, 2025 | News

Stay Connected